Pejler, Gunnar
- Department of Animal Biosciences, Swedish University of Agricultural Sciences
- Uppsala University
Research article2019Peer reviewedOpen access
Desbiens, Louisane; Lapointe, Catherine; Gendron, Louis; Gharagozloo, Marjan; Vincent, Laurence; Pejler, Gunnar; Gris, Denis; D'Orleans-Juste, Pedro
Multiple sclerosis is a neurodegenerative disease affecting predominantly female patients between 20 and 45 years of age. We previously reported the significant contribution of mouse mast cell protease 4 (mMCP-4) in the synthesis of endothelin-1 (ET-1) in healthy mice and in a murine model of experimental autoimmune encephalomyelitis (EAE). In the current study, the cardiovascular effects of ET-1 and big endothelin-1 (big-ET-1) administered systemically or intrathecally were assessed in the early preclinical phase of EAE in telemetry instrumented/conscious mice. Chymase-specific enzymatic activity was also measured in the lung, brain, and mast cell extracts in vitro. Finally, the impact of EAE immunization was studied on the pulmonary and brain mRNA expression of different genes of the endothelin pathway, interleukin-33 (IL-33), and monitoring of immunoreactive tumor necrosis factor-alpha (TNF-alpha). Systemically or intrathecally administered big-ET-1 triggered increases in blood pressure in conscious mice. One week post-EAE, the pressor responses to big-ET-1 were potentiated in wild-type (WT) mice but not in mMCP-4 knockout (KO) mice. EAE triggered mMCP-4-specific activity in cerebral homogenates and peritoneal mast cells. Enhanced pulmonary, but not cerebral preproendothelin-1 and IL-33 mRNA were found in KO mice and further increased 1 week post-EAE immunization, but not in WT animals. Finally, TNF-alpha levels were also increased in serum from mMCP-4 KO mice, but not WT, 1 week post-EAE. Our study suggests that mMCP-4 activity is enhanced both centrally and systemically in a mouse model of EAE.
Journal of Pharmacology and Experimental Therapeutics
2019, Volume: 370, number: 3, pages: 437-446 Publisher: AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
Pharmacology and Toxicology
DOI: https://doi.org/10.1124/jpet.118.256016
https://res.slu.se/id/publ/101981